Skip to main content

Connect on Coronavirus: BSI published research

Here you can find international COVID-19 research that has been published in the Society’s official journals, Clinical & Experimental Immunology (CEI) and ImmunologyWe have also produced summaries of the research for a general public audience, exploring why and how the research was conducted, what the results can tell us and what further work is needed. 


Clinical & Experimental Immunology

COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases
D. Baker, C.A.K Roberts, G. Pryce, A. S. Kang, M. Marta, S. Reyes, K. Schmierer, G. Giovannoni & S. Amor

How do immunotherapy treatments for autoimmune diseases affect the response to COVID-19 and a potential vaccine?

First published 16 July 2020

Read the general audience summary

 

Using IL‐2R/lymphocytes for predicting the clinical progression of patients with COVID‐19
H. Hou, B. Zhang, H. Huang, Y. Luo, S. Wu, G. Tang, W. Liu, L. Mao, L. Mao, F. Wang & Z. Sun.

Study indicates testing COVID-19 patients for particular proteins could help predict later disease severity. 

First published 4 May 2020

Read the general audience summary


Immunology

Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS‐CoV‐2
N. Novak and B. Cabanillas

Review of the relationship between SARS-CoV-2 infection and asthma.

First published 20 July 2020

Read the general audience summary

 

Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
M. Tan, Y. Liu, R. Zhou, X. Deng, F. Li, K. Liagn & Y. Shi. ​

Study of immune response in COVID-19 patients points to key indicators of disease severity.

First published 27 May 2020

Read the general audience summary

 

The early landscape of COVID‐19 vaccine development in the UK and rest of the world.
H.R. Sharpe, C. Gilbride, E. Allen, S. Belij‐Rammerstorfer, C. Bissett, K. Ewer & T. Lambe.​​

Review of the progress made so far in the development of a vaccine for COVID-19.

First published 27 May 2020

Read the general audience summary